JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹0.47 Cr | ₹-1.37 Cr | ₹2.54 Cr | ₹-0.04 Cr | ₹1.31 Cr |
What is the latest Net Cash Inflow / Outflow ratio of JENBURKT PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹0.47 Cr |
Mar2023 | ₹-1.37 Cr |
Mar2022 | ₹2.54 Cr |
Mar2021 | ₹-0.04 Cr |
Mar2020 | ₹1.31 Cr |
How is Net Cash Inflow / Outflow of JENBURKT PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹0.47 Cr | Positive | |
Mar2023 | ₹-1.37 Cr | Negative | |
Mar2022 | ₹2.54 Cr | Positive | |
Mar2021 | ₹-0.04 Cr | Negative | |
Mar2020 | ₹1.31 Cr | - |
Compare Net Cash Inflow / Outflow of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹494.3 Cr | -13.9% | 3% | 76.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,914.0 Cr | -0.7% | -6.2% | 52.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -3.1% | -5.5% | 66.2% | Stock Analytics | |
CIPLA | ₹121,563.0 Cr | -4.3% | -4.2% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,939.0 Cr | -3.2% | -5.9% | 16.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,960.7 Cr | -0.9% | -8.9% | 53.3% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -13.9% |
3% |
76.1% |
SENSEX | -3.3% |
-5.2% |
19.8% |
You may also like the below Video Courses